Immune Initiates Bertilimumab Phase II Clinical Trial in Ulcerative Colitis

News   Feb 22, 2013

 
Immune Initiates Bertilimumab Phase II Clinical Trial in Ulcerative Colitis
 
 
 
FURTHER INFORMATION
 

Like what you just read? You can find similar content on the communities below.

Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 
 

Comments | 0 ADD COMMENT